Customized care 2020: how medical sequencing and network biology will enable personalized medicine

Applications of next-generation nucleic acid sequencing technologies will lead to the development of precision diagnostics that will, in turn, be a major technology enabler of precision medicine. Terabyte-scale, multidimensional data sets derived using these technologies will be used to reverse engineer the specific disease networks that underlie individual patients’ conditions. Modeling and simulation of these networks in the presence of virtual drugs, and combinations of drugs, will identify the most efficacious therapy for precision medicine and customized care. In coming years the practice of medicine will routinely employ network biology analytics supported by high-performance supercomputing.

[1]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[2]  中尾 光輝,et al.  KEGG(Kyoto Encyclopedia of Genes and Genomes)〔和文〕 (特集 ゲノム医学の現在と未来--基礎と臨床) -- (データベース) , 2000 .

[3]  J. Shendure.  The beginning of the end for microarrays? , 2008, Nature Methods.

[4]  Joakim Lundeberg,et al.  Generations of sequencing technologies. , 2009, Genomics.

[5]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[6]  S. Horvath,et al.  Variations in DNA elucidate molecular networks that cause disease , 2008, Nature.

[7]  John J Tyson,et al.  Modeling molecular regulatory networks with JigCell and PET. , 2009, Methods in molecular biology.

[8]  R. Vossen,et al.  Deep sequencing-based expression analysis shows major advances in robustness, resolution and inter-lab portability over five microarray platforms , 2008, Nucleic acids research.

[9]  Eric E. Schadt,et al.  Moving toward a system genetics view of disease , 2007, Mammalian Genome.

[10]  Eric E. Walk.  The role of pathologists in the era of personalized medicine. , 2009, Archives of pathology & laboratory medicine.

[11]  Hanlee P. Ji,et al.  Next-generation DNA sequencing , 2008, Nature Biotechnology.

[12]  Clayton M. Christensen,et al.  The Innovator's Prescription: A Disruptive Solution for Health Care , 2008 .

[13]  Elaine R Mardis,et al.  Anticipating the $1,000 genome , 2006, Genome Biology.

[14]  H. Kitano,et al.  Computational systems biology , 2002, Nature.

[15]  Y. Lazebnik.  Can a biologist fix a radio? — or, what I learned while studying apoptosis , 2004, Biochemistry (Moscow).

[16]  D. Lauffenburger,et al.  Input–output behavior of ErbB signaling pathways as revealed by a mass action model trained against dynamic data , 2009, Molecular systems biology.

[17]  H. Stefánsson,et al.  Genetics of gene expression and its effect on disease , 2008, Nature.

[18]  Annelise E Barron,et al.  Advantages and limitations of next‐generation sequencing technologies: A comparison of electrophoresis and non‐electrophoresis methods , 2008, Electrophoresis.

[19]  John Quackenbush,et al.  What would you do if you could sequence everything? , 2008, Nature Biotechnology.

[20]  Douglas B. Kell,et al.  System Modeling in Cell Biology From Concepts to Nuts and Bolts , 2005 .

[21]  S. V. Aksenov,et al.  A systems biology dynamical model of mammalian G1 cell cycle progression , 2007, Molecular systems biology.

[22]  Vipul Periwal,et al.  System Modeling in Cellular Biology: From Concepts to Nuts and Bolts , 2006 .

[23]  B. Palsson.  Systems Biology: Properties of Reconstructed Networks , 2006 .